Purpose: Our goal was to describe the imaging features of hereditary p
apillary renal cancer syndrome (HPRC), a new familial cancer syndrome.
Method: Members of seven kindreds with HPRC comprising 78 individuals
were screened with contrast-enhanced CT and abdominal US. MRI was per
formed in three patients. Enhancement values and doubling times of sol
id masses were determined from CT scans. Results: Seventeen of 78 (22%
) patients were affected. The HPRCs demonstrated lower enhancement (me
an change in enhancement = 31 HU) than a comparable group of clear cel
l tumors (mean change in enhancement = 67 HU; p = 0.00001). The median
tumor doubling time on serial CT was 18 months. The HPRCs were relati
vely hypovascular, enhanced uniformly, and grew slowly. Therefore, car
eful measurements of the region of interest should be obtained before
and after intravenous administration of contrast medium. Though US det
ected only 45% of the lesions visualized on CT, it was useful in deter
mining if lesions were cystic. Contrast-enhanced MRI demonstrated simi
lar characteristics to contrast-enhanced CT. Conclusion: The tumors of
patients with HPRC pose some diagnostic difficulties because they can
be missed by US, are small, and enhance poorly on CT. CT is preferabl
e to US as a screening tool because of its higher sensitivity in detec
ting small lesions, and when contrast media cannot be administered, MR
is a suitable alternative to CT.